ChromaTOF 4.32
ChromaTOF 4.32 is now available for all your LECO instrument systems.
ChromaTOF 4.32 is now available for all your LECO instrument systems. LECO have maintained the continuity of one software platform for all your needs whilst incorporating your wishes.
New features include Variable Modulation Times within each GC×GC chromatographic run for a truly optimised separation. This maximizes resolution in both the first and second dimensions and is compatible with both traditional LN2 and Consumable Free (CF) GC×GC systems. Also available is the LECO/Fiehn Metabolomics Library with over 1,100 spectra of 700 unique metabolomics for metabolite identification in your most complex samples. Fully integrated within ChromaTOF, the library works seamlessly with the software's Library Search function to automatically search for analyte matches without the need for importing or exporting data.
The logical database structure gives the visual benefits of seeing everything directly. Hence, all options are readily located for ease of use. Complimentary to this are the unlimited individually designed workspaces for every operator. The benefit of this flexible working style is an easy to drive acquisition and data processing software platform that can be customised to each operators preferences.
The newly implemented features are built on a history of dedication and continuous development ensuring LECO continues to provide the market leading comprehensive software package known as ChromaTOF. For more information contact the LECO Separation Science team.
Contact details
LECO European Technical Centre (ETC)
Marie-Bernays-Ring 31
41199 Mönchengladbach
Germany
Tel: +49 (0)2166 687 -104 or -107
Email: SepSci@leco.de
Web address: www.leco-etc.com
New TRC Facility Accelerates Innovation and Delivery
April 25th 2025We’ve expanded our capabilities with a state-of-the-art, 200,000 sq ft TRC facility in Toronto, completed in 2024 and staffed by over 100 PhD- and MSc-level scientists. This investment enables the development of more innovative compounds, a broader catalogue and custom offering, and streamlined operations for faster delivery. • Our extensive range of over 100,000 high-quality research chemicals—including APIs, metabolites, and impurities in both native and stable isotope-labelled forms—provides essential tools for uncovering molecular disease mechanisms and exploring new opportunities for therapeutic intervention.
New Guide: Characterising Impurity Standards – What Defines “Good Enough?”
April 25th 2025Impurity reference standards (IRSs) are essential for accurately identifying and quantifying impurities in pharmaceutical development and manufacturing. Yet, with limited regulatory guidance on how much characterisation is truly required for different applications, selecting the right standard can be challenging. To help, LGC has developed a new interactive multimedia guide, packed with expert insights to support your decision-making and give you greater confidence when choosing the right IRS for your specific needs.
